(Q44783387)

6 December 2017

Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology (English)

1 reference

6 December 2017

0 references

0 references

1 reference

Kaushal V

1

1 reference

6 December 2017

Kaushal GP

series ordinal

2

1 reference

6 December 2017

Melkaveri SN

series ordinal

3

1 reference

6 December 2017

Mehta P

series ordinal

4

1 reference

6 December 2017

1 February 2004

1 reference

Journal of Thrombosis and Haemostasis

6 December 2017

1 reference

6 December 2017

2

1 reference

6 December 2017

2

1 reference

6 December 2017

327-334

1 reference

Antitumor activity of thalidomide in refractory multiple myeloma

6 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

A role for thrombin receptor signaling in endothelial cells during embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Coagulation cascade proteases and tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Inhibition of human angiogenesis with heparin and hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Evidence that nitric oxide is an endogenous antiangiogenic mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Clinical pharmacology of thalidomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: role of oxidant-induced iron signaling in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

A protective role for protease-activated receptors in the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7933.2003.00573.X

10.1046/J.1538-7933.2003.00573.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference